Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
allergic rhinitis
MeSH D065631 - allergic rhinitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012220:
Rhinitis
40 Companies
13 Drugs
$
Success rate
D012130:
Respiratory hypersensitivity
3 Companies
1 Drug
$
Success rate
D065631:
Â
Allergic rhinitis
47 Companies
2 Drugs
$
Success rate
D006255:
Allergic rhinitis seasonal
31 Companies
10 Drugs
$
Success rate
D012221:
Allergic rhinitis perennial
209 Companies
69 Drugs
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
54
%
20/37
Phase 2
57
%
13/23
Phase 3
86
%
24/28
Approved:
3
Overall Success rate:
26%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Prednisone
,
Terfenadine
,
Sodium chloride
Bausch Health Companies
Prednisone
,
Corticoids
,
Arm1
,
Arm2
Merck & Co
Prednisone
,
Cortisone
,
Cortisone acetate
,
Alfacalcidol
,
Bilastine
,
Terfenadine
,
Procaterol
,
Aspartame
,
Nepidermin
,
Levosalbutamol
,
Corticoids
,
Cycloplegics
,
Mydriatics
Bayer
Prednisone
,
Alfacalcidol
,
Terfenadine
,
Cycloplegics
,
Arm1
,
Mydriatics
,
Arm2
,
Mydfrin
Pfizer
Prednisone
,
Benzocaine
,
Terfenadine
,
Dexibuprofen
,
Sodium chloride
,
Mydfrin
Sun Pharmaceutical Industries
Prednisone
1
2
3
4
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use